![LJK LJK](https://data.pdbj.org/pdbjplus/data/cc/svg/LJK.svg) | LJK | Name: | 3-methyl-N-(2-methylbutan-2-yl)-1H-pyrazole-5-carboxamide | Formula: | C10 H17 N3 O | SMILES: | O=C(NC(C)(C)CC)c1cc(C)n[NH]1 | InChi: | InChI=1S/C10H17N3O/c1-5-10(3,4)11-9(14)8-6-7(2)12-13-8/h6H,5H2,1-4H3,(H,11,14)(H,12,13) | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 3-methyl-N-(2-methylbutan-2-yl)-1H-pyrazole-5-carboxamide |
|
![LK6 LK6](https://data.pdbj.org/pdbjplus/data/cc/svg/LK6.svg) | LK6 | Name: | N-[(3R)-3-methyl-1,1-dioxo-1lambda~6~-thiolan-3-yl]cyclopropanecarboxamide | Formula: | C9 H15 N O3 S | SMILES: | O=S1(=O)CCC(C)(NC(=O)C2CC2)C1 | InChi: | InChI=1S/C9H15NO3S/c1-9(4-5-14(12,13)6-9)10-8(11)7-2-3-7/h7H,2-6H2,1H3,(H,10,11)/t9-/m1/s1 | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | N-[(3R)-3-methyl-1,1-dioxo-1lambda~6~-thiolan-3-yl]cyclopropanecarboxamide |
|
![LKL LKL](https://data.pdbj.org/pdbjplus/data/cc/svg/LKL.svg) | LKL | Name: | 2-[(5-chloro-3-fluoropyridin-2-yl)(methyl)amino]ethan-1-ol | Formula: | C8 H10 Cl F N2 O | SMILES: | Fc1cc(Cl)cnc1N(C)CCO | InChi: | InChI=1S/C8H10ClFN2O/c1-12(2-3-13)8-7(10)4-6(9)5-11-8/h4-5,13H,2-3H2,1H3 | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 2-[(5-chloro-3-fluoropyridin-2-yl)(methyl)amino]ethan-1-ol |
|
![LL0 LL0](https://data.pdbj.org/pdbjplus/data/cc/svg/LL0.svg) | LL0 | Name: | 2-(difluoromethoxy)benzene-1-sulfonamide | Formula: | C7 H7 F2 N O3 S | SMILES: | O=S(N)(=O)c1ccccc1OC(F)F | InChi: | InChI=1S/C7H7F2NO3S/c8-7(9)13-5-3-1-2-4-6(5)14(10,11)12/h1-4,7H,(H2,10,11,12) | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 2-(difluoromethoxy)benzene-1-sulfonamide |
|
![LLU LLU](https://data.pdbj.org/pdbjplus/data/cc/svg/LLU.svg) | LLU | Name: | (2S)-2-(2-fluorophenoxy)propanoic acid | Formula: | C9 H9 F O3 | SMILES: | CC(Oc1ccccc1F)C(=O)O | InChi: | InChI=1S/C9H9FO3/c1-6(9(11)12)13-8-5-3-2-4-7(8)10/h2-6H,1H3,(H,11,12)/t6-/m0/s1 | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | (2S)-2-(2-fluorophenoxy)propanoic acid |
|
![LNS LNS](https://data.pdbj.org/pdbjplus/data/cc/svg/LNS.svg) | LNS | Name: | 6-(methylcarbamoyl)pyridine-2-carboxylic acid | Formula: | C8 H8 N2 O3 | SMILES: | OC(=O)c1cccc(n1)C(=O)NC | InChi: | InChI=1S/C8H8N2O3/c1-9-7(11)5-3-2-4-6(10-5)8(12)13/h2-4H,1H3,(H,9,11)(H,12,13) | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 6-(methylcarbamoyl)pyridine-2-carboxylic acid |
|
![LO6 LO6](https://data.pdbj.org/pdbjplus/data/cc/svg/LO6.svg) | LO6 | Name: | 2-(difluoromethoxy)-1-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethan-1-one | Formula: | C9 H15 F2 N O3 | SMILES: | O=C(COC(F)F)N1CC(C)OC(C)C1 | InChi: | InChI=1S/C9H15F2NO3/c1-6-3-12(4-7(2)15-6)8(13)5-14-9(10)11/h6-7,9H,3-5H2,1-2H3/t6-,7+ | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 2-(difluoromethoxy)-1-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethan-1-one |
|
![LPU LPU](https://data.pdbj.org/pdbjplus/data/cc/svg/LPU.svg) | LPU | Name: | 1-(methanesulfonyl)piperidin-4-ol | Formula: | C6 H13 N O3 S | SMILES: | OC1CCN(CC1)S(=O)(C)=O | InChi: | InChI=1S/C6H13NO3S/c1-11(9,10)7-4-2-6(8)3-5-7/h6,8H,2-5H2,1H3 | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 1-(methanesulfonyl)piperidin-4-ol |
|
![LQ3 LQ3](https://data.pdbj.org/pdbjplus/data/cc/svg/LQ3.svg) | LQ3 | Name: | (5S)-5-(difluoromethoxy)pyridin-2(5H)-one | Formula: | C6 H5 F2 N O2 | SMILES: | O=C1C=CC(OC(F)F)C=N1 | InChi: | InChI=1S/C6H5F2NO2/c7-6(8)11-4-1-2-5(10)9-3-4/h1-4,6H/t4-/m0/s1 | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | (5S)-5-(difluoromethoxy)pyridin-2(5H)-one |
|
![LQI LQI](https://data.pdbj.org/pdbjplus/data/cc/svg/LQI.svg) | LQI | Name: | (1-benzofuran-2-yl)(4-methylpiperidin-1-yl)methanone | Formula: | C15 H17 N O2 | SMILES: | CC1CCN(CC1)C(=O)c1cc2ccccc2o1 | InChi: | InChI=1S/C15H17NO2/c1-11-6-8-16(9-7-11)15(17)14-10-12-4-2-3-5-13(12)18-14/h2-5,10-11H,6-9H2,1H3 | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | (1-benzofuran-2-yl)(4-methylpiperidin-1-yl)methanone |
|
![LQP LQP](https://data.pdbj.org/pdbjplus/data/cc/svg/LQP.svg) | LQP | Name: | 2-(difluoromethoxy)-1-[(3aR,6aS)-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]ethan-1-one | Formula: | C10 H15 F2 N O2 | SMILES: | FC(F)OCC(=O)N1CC2CCCC2C1 | InChi: | InChI=1S/C10H15F2NO2/c11-10(12)15-6-9(14)13-4-7-2-1-3-8(7)5-13/h7-8,10H,1-6H2/t7-,8+ | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 2-(difluoromethoxy)-1-[(3aR,6aS)-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]ethan-1-one |
|
![LQV LQV](https://data.pdbj.org/pdbjplus/data/cc/svg/LQV.svg) | LQV | Name: | (2S)-N-(5-methylpyridin-2-yl)oxolane-2-carboxamide | Formula: | C11 H14 N2 O2 | SMILES: | O=C(Nc1ccc(C)cn1)C1CCCO1 | InChi: | InChI=1S/C11H14N2O2/c1-8-4-5-10(12-7-8)13-11(14)9-3-2-6-15-9/h4-5,7,9H,2-3,6H2,1H3,(H,12,13,14)/t9-/m0/s1 | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | (2S)-N-(5-methylpyridin-2-yl)oxolane-2-carboxamide |
|
![LR9 LR9](https://data.pdbj.org/pdbjplus/data/cc/svg/LR9.svg) | LR9 | Name: | 3-amino-N-ethyl-N-methylbenzamide | Formula: | C10 H14 N2 O | SMILES: | O=C(c1cc(N)ccc1)N(C)CC | InChi: | InChI=1S/C10H14N2O/c1-3-12(2)10(13)8-5-4-6-9(11)7-8/h4-7H,3,11H2,1-2H3 | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 3-amino-N-ethyl-N-methylbenzamide |
|
![LRF LRF](https://data.pdbj.org/pdbjplus/data/cc/svg/LRF.svg) | LRF | Name: | N~2~-(4-cyano-3-methyl-1,2-thiazol-5-yl)-N~2~-methylglycinamide | Formula: | C8 H10 N4 O S | SMILES: | N#Cc1c(snc1C)N(C)CC(N)=O | InChi: | InChI=1S/C8H10N4OS/c1-5-6(3-9)8(14-11-5)12(2)4-7(10)13/h4H2,1-2H3,(H2,10,13) | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | N~2~-(4-cyano-3-methyl-1,2-thiazol-5-yl)-N~2~-methylglycinamide |
|
![LRR LRR](https://data.pdbj.org/pdbjplus/data/cc/svg/LRR.svg) | LRR | Name: | 1-(morpholin-4-yl)-4-phenylbutan-1-one | Formula: | C14 H19 N O2 | SMILES: | O=C(CCCc1ccccc1)N1CCOCC1 | InChi: | InChI=1S/C14H19NO2/c16-14(15-9-11-17-12-10-15)8-4-7-13-5-2-1-3-6-13/h1-3,5-6H,4,7-12H2 | Definition date: | 2022-03-04 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 1-(morpholin-4-yl)-4-phenylbutan-1-one |
|
![I7K I7K](https://data.pdbj.org/pdbjplus/data/cc/svg/I7K.svg) | I7K | Name: | 1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-4-carboxylic acid | Formula: | C20 H17 N O8 S | SMILES: | O=S(=O)(c1cc2C(=O)c3ccccc3C(=O)c2c(O)c1O)N1CCC(CC1)C(=O)O | InChi: | InChI=1S/C20H17NO8S/c22-16-11-3-1-2-4-12(11)17(23)15-13(16)9-14(18(24)19(15)25)30(28,29)21-7-5-10(6-8-21)20(26)27/h1-4,9-10,24-25H,5-8H2,(H,26,27) | Definition date: | 2022-01-20 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-4-carboxylic acid |
|
![I7N I7N](https://data.pdbj.org/pdbjplus/data/cc/svg/I7N.svg) | I7N | Name: | N-[(3R)-1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carbonyl]-L-aspartic acid | Formula: | C24 H22 N2 O11 S | SMILES: | O=S(=O)(c1cc2C(=O)c3ccccc3C(=O)c2c(O)c1O)N1CCCC(C1)C(=O)NC(CC(=O)O)C(=O)O | InChi: | InChI=1S/C24H22N2O11S/c27-17(28)9-15(24(34)35)25-23(33)11-4-3-7-26(10-11)38(36,37)16-8-14-18(22(32)21(16)31)20(30)13-6-2-1-5-12(13)19(14)29/h1-2,5-6,8,11,15,31-32H,3-4,7,9-10H2,(H,25,33)(H,27,28)(H,34,35)/t11-,15+/m1/s1 | Definition date: | 2022-01-21 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | N-[(3R)-1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carbonyl]-L-aspartic acid |
|
![I7V I7V](https://data.pdbj.org/pdbjplus/data/cc/svg/I7V.svg) | I7V | Name: | (3R)-1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carboxylic acid | Formula: | C20 H17 N O8 S | SMILES: | O=S(=O)(c1cc2C(=O)c3ccccc3C(=O)c2c(O)c1O)N1CCCC(C1)C(=O)O | InChi: | InChI=1S/C20H17NO8S/c22-16-11-5-1-2-6-12(11)17(23)15-13(16)8-14(18(24)19(15)25)30(28,29)21-7-3-4-10(9-21)20(26)27/h1-2,5-6,8,10,24-25H,3-4,7,9H2,(H,26,27)/t10-/m1/s1 | Definition date: | 2022-01-21 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | (3R)-1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carboxylic acid |
|
![I8Q I8Q](https://data.pdbj.org/pdbjplus/data/cc/svg/I8Q.svg) | I8Q | Name: | 4-amino-3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid | Formula: | C14 H9 N O6 S | SMILES: | O=S(=O)(O)c1cc2C(=O)c3ccccc3C(=O)c2c(N)c1O | InChi: | InChI=1S/C14H9NO6S/c15-11-10-8(5-9(14(11)18)22(19,20)21)12(16)6-3-1-2-4-7(6)13(10)17/h1-5,18H,15H2,(H,19,20,21) | Definition date: | 2022-01-24 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 4-amino-3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid |
|
![I8U I8U](https://data.pdbj.org/pdbjplus/data/cc/svg/I8U.svg) | I8U | Name: | 3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid | Formula: | C14 H8 O6 S | SMILES: | O=S(=O)(O)c1cc2c(cc1O)C(=O)c1ccccc1C2=O | InChi: | InChI=1S/C14H8O6S/c15-11-5-9-10(6-12(11)21(18,19)20)14(17)8-4-2-1-3-7(8)13(9)16/h1-6,15H,(H,18,19,20) | Definition date: | 2022-01-24 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid |
|
![I8Y I8Y](https://data.pdbj.org/pdbjplus/data/cc/svg/I8Y.svg) | I8Y | Name: | 3-amino-4-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid | Formula: | C14 H9 N O6 S | SMILES: | O=S(=O)(O)c1cc2C(=O)c3ccccc3C(=O)c2c(O)c1N | InChi: | InChI=1S/C14H9NO6S/c15-11-9(22(19,20)21)5-8-10(14(11)18)13(17)7-4-2-1-3-6(7)12(8)16/h1-5,18H,15H2,(H,19,20,21) | Definition date: | 2022-01-24 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | 3-amino-4-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid |
|
![I91 I91](https://data.pdbj.org/pdbjplus/data/cc/svg/I91.svg) | I91 | Name: | N-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)glycine | Formula: | C16 H11 N O7 S | SMILES: | O=C(O)CNS(=O)(=O)c1cc2c(cc1O)C(=O)c1ccccc1C2=O | InChi: | InChI=1S/C16H11NO7S/c18-12-5-10-11(6-13(12)25(23,24)17-7-14(19)20)16(22)9-4-2-1-3-8(9)15(10)21/h1-6,17-18H,7H2,(H,19,20) | Definition date: | 2022-01-24 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | N-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)glycine |
|
![I99 I99](https://data.pdbj.org/pdbjplus/data/cc/svg/I99.svg) | I99 | Name: | (3R)-1-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carboxylic acid | Formula: | C20 H17 N O7 S | SMILES: | O=S(=O)(c1cc2C(=O)c3ccccc3C(=O)c2cc1O)N1CCCC(C1)C(=O)O | InChi: | InChI=1S/C20H17NO7S/c22-16-8-14-15(19(24)13-6-2-1-5-12(13)18(14)23)9-17(16)29(27,28)21-7-3-4-11(10-21)20(25)26/h1-2,5-6,8-9,11,22H,3-4,7,10H2,(H,25,26)/t11-/m1/s1 | Definition date: | 2022-01-24 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | (3R)-1-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carboxylic acid |
|
![I9C I9C](https://data.pdbj.org/pdbjplus/data/cc/svg/I9C.svg) | I9C | Name: | methyl N-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)glycinate | Formula: | C17 H13 N O7 S | SMILES: | O=C(OC)CNS(=O)(=O)c1cc2c(cc1O)C(=O)c1ccccc1C2=O | InChi: | InChI=1S/C17H13NO7S/c1-25-15(20)8-18-26(23,24)14-7-12-11(6-13(14)19)16(21)9-4-2-3-5-10(9)17(12)22/h2-7,18-19H,8H2,1H3 | Definition date: | 2022-01-24 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | methyl N-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)glycinate |
|
![I9F I9F](https://data.pdbj.org/pdbjplus/data/cc/svg/I9F.svg) | I9F | Name: | dimethyl (2R)-2-hydroxy-2-{2-[4-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperazin-1-yl]-2-oxoethyl}butanedioate | Formula: | C26 H26 N2 O11 S | SMILES: | O=S(=O)(c1cc2C(=O)c3ccccc3C(=O)c2cc1O)N1CCN(CC1)C(=O)CC(O)(CC(=O)OC)C(=O)OC | InChi: | InChI=1S/C26H26N2O11S/c1-38-22(31)14-26(35,25(34)39-2)13-21(30)27-7-9-28(10-8-27)40(36,37)20-12-18-17(11-19(20)29)23(32)15-5-3-4-6-16(15)24(18)33/h3-6,11-12,29,35H,7-10,13-14H2,1-2H3/t26-/m1/s1 | Definition date: | 2022-01-24 | Last modified: | 2022-03-11 | Release date: | 2022-03-16 | Identifier: | dimethyl (2R)-2-hydroxy-2-{2-[4-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperazin-1-yl]-2-oxoethyl}butanedioate |
|